Bone marrow microenvironment in myelomagenesis: its potential role in early diagnosis
- 1 May 2010
- journal article
- review article
- Published by Informa UK Limited in Expert Review of Molecular Diagnostics
- Vol. 10 (4), 465-480
- https://doi.org/10.1586/erm.10.31
Abstract
Multiple myeloma (MM) is the second most common hematological malignancy, with an overall survival of 4-6 years. It is always preceded by a premalignant stage called monoclonal gammopathy of unknown significance (MGUS). Importantly, at this time we lack reliable predictors to determine who will progress from MGUS to MM, and who will remain stable. The bone marrow microenvironment plays a key role in myelomagenesis (growth, survival and migration of malignant plasma cells). In the present review, we summarize and discuss our current understanding of the bone marrow microenvironment and its compartments in relation to myelomagenesis. Although it remains to be proven, we believe that an improved characterization of the cellular constituents, the extracellular matrix components and the soluble factors of the bone marrow could open up novel avenues to better understand underlying mechanisms of the transformation from MGUS to MM. Ultimately, this will lead to the development of early treatment of high-risk precursor disease aimed to delay/prevent MM.Keywords
This publication has 143 references indexed in Scilit:
- Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironmentNature, 2009
- Osteoblastic regulation of B lymphopoiesis is mediated by G s α-dependent signaling pathwaysProceedings of the National Academy of Sciences, 2008
- Vasculogenic mimicry by bone marrow macrophages in patients with multiple myelomaOncogene, 2007
- The Differentiation and Stress Response Factor XBP-1 Drives Multiple Myeloma PathogenesisCancer Cell, 2007
- Bone marrow mesenchymal stem cells are abnormal in multiple myelomaLeukemia, 2007
- Enhancement of clonogenicity of human multiple myeloma by dendritic cellsThe Journal of Experimental Medicine, 2006
- Heparan sulphate proteoglycans are essential for the myeloma cell growth activity of EGF-family ligands in multiple myelomaOncogene, 2006
- Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cellsNature, 2006
- Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cellsNature Medicine, 1996
- Bone marrow angiogenesis and progression in multiple myelomaBritish Journal of Haematology, 1994